Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease

NCT03823404 is registered in ClinicalTrials.gov with Cortexyme Inc. as lead sponsor.

NCT NCT03823404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03823404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
Lead sponsor
Cortexyme Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
March 28, 2019
Completion date
January 1, 2022
Enrollment
643 (actual)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease